S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The single greatest medical breakthrough of all time? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Biden's latest bailout--terrible for America? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: World stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The single greatest medical breakthrough of all time? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Biden's latest bailout--terrible for America? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: World stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The single greatest medical breakthrough of all time? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Biden's latest bailout--terrible for America? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: World stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The single greatest medical breakthrough of all time? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Biden's latest bailout--terrible for America? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: World stocks mixed as Wall St inches toward bull market
NASDAQ:SRAX

SRAX (SRAX) Price Target & Analyst Ratings

$0.34
-0.11 (-24.30%)
(As of 06/6/2023 ET)
Compare
Today's Range
$0.34
$0.35
50-Day Range
$0.25
$0.58
52-Week Range
$0.02
$4.31
Volume
624 shs
Average Volume
20,731 shs
Market Capitalization
$9.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25

SRAX Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 2 Analyst Ratings

Consensus Analyst Price Target

$5.25
1,431.73% Upside
High Prediction$6.00
Average Prediction$5.25
Low Prediction$4.50
TypeCurrent
6/7/22 to 6/7/23
1 Month Ago
5/8/22 to 5/8/23
3 Months Ago
3/9/22 to 3/9/23
1 Year Ago
6/7/21 to 6/7/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$5.25$5.25$5.25$13.25
Predicted Upside1,431.73% Upside159.26% Upside159.26% Upside273.06% Upside
Get SRAX Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SRAX and its competitors with MarketBeat's FREE daily newsletter.


SRAX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SRAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

SRAX Stock vs. The Competition

TypeSRAXBusiness Services CompaniesS&P 500
Consensus Rating Score
3.00
2.57
2.49
Consensus RatingBuyBuyHold
Predicted Upside1,431.73% Upside274.42% Upside221.87% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/13/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$7.50 ➝ $4.50+110.28%
9/26/2022Dawson James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$10.00 ➝ $6.00+214.14%
(Data available from 6/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SRAX Price Target - Frequently Asked Questions

What is SRAX's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for SRAX stock is Buy based on the current 2 buy ratings for SRAX. The average twelve-month price prediction for SRAX is $5.25 with a high price target of $6.00 and a low price target of $4.50. Learn more on SRAX's analyst rating history.

Do Wall Street analysts like SRAX more than its competitors?

Analysts like SRAX more than other Business Services companies. The consensus rating score for SRAX is 3.00 while the average consensus rating score for business services companies is 2.57. Learn more on how SRAX compares to other companies.

Does SRAX's stock price have much upside?

According to analysts, SRAX's stock has a predicted upside of 159.26% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:SRAX) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -